Main Article Content

Abstract

Primary central nervous system lymphoma represents a rare and aggressive variant of non-Hodgkin lymphoma that remains confined to the central nervous system without systemic involvement at the time of diagnosis.[1] We present a case of a 48-year-old immunocompetent male who initially received a diagnosis of multiple sclerosis but was subsequently found to harbor PCNSL (Primary Central Nervous System Lymphoma) of the diffuse large B-cell type.[2] This case highlights the considerable clinical and radiological similarities between PCNSL and demyelinating disorders, demonstrating the critical importance of obtaining tissue diagnosis through biopsy and comprehensive immunohistochemical evaluation for accurate diagnosis and timely therapeutic intervention.[1]


Primary central nervous system lymphoma accounts for approximately 3.3% of all primary brain tumors. In immunocompetent patients, the vast majority of PCNSL cases originate from germinal center B-cells and develop within the brain parenchyma, spinal cord, cerebrospinal fluid compartment, or intraocular structures without evidence of systemic disease. The diagnosis of PCNSL poses significant challenges due to its non-specific clinical presentation, ambiguous neuroimaging characteristics, and often unrevealing cerebrospinal fluid findings, leading to frequent misdiagnosis. Through this case presentation, we aim to emphasize the importance of including PCNSL in the differential diagnosis when magnetic resonance imaging demonstrates non-enhancing, diffusely infiltrative lesions.[1]

Article Details

How to Cite
Sunidhi Kumari S., Syed Areeb Yazdani, Nagarjuna Chary, & Naval Kishore Bajaj. (2026). Primary Central Nervous System Lymphoma Masquerading as Multiple Sclerosis - A Case Report. Journal of Evolution of Medical and Dental Sciences, 15(3), 71–75. https://doi.org/10.14260/jemds.v15i3.849

References

  1. Chen H, Dong H. A rare case of nonenhancing primary central nervous system lymphoma mimic multiple sclerosis. Neurosciences 2015;20(4):380-4.
  2. Khalil NCN, Iwaiwi BI, Hammad S, et al. A necrotic primary central nervous system lymphoma in immunocompetent patient with MYC and BCL6 rearrangements (double-hit lymphoma): a case report. Oxf Med Case Rep 2023;2023(3):omad026.
  3. Liu J, Wang Y, Liu Y, et al. Immunohistochemical profile and prognostic significance in primary central nervous system lymphoma: analysis of 89 cases. Oncol Lett 2017;14(5):5505-12.
  4. Puligundla CK, Bala S, Karnam AK, et al. Clinicopathological features and outcomes in primary central nervous system lymphoma: A 10‑year experience. Indian J Med Paediatr Oncol 2017;38(4):478–82.
  5. Batchelor TT. Primary central nervous system lymphoma. Hematology 2016;2016(1):379-85.
  6. Joshi A, Deshpande S, Bayaskar M. Primary CNS lymphoma in Immunocompetent patients: appearances on conventional and advanced imaging with review of literature. J Radiol Case Rep 2022;16(7):1-17.
  7. Ferreri AJM, Illerhaus G, Doorduijn JK, et al. Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2024;35(6):491–507.
  8. Van Rooij JLM, Wessels PH, Delemarre EM, et al. New biomarkers for the diagnosis of primary central nervous system lymphoma in CSF: a multicenter retrospective cohort study. Neuro-Oncol Adv 2025;7(1):vdaf208.
  9. Lyons MK, Boucher OK, Birch BD, et al. The development of primary central nervous system b-cell lymphoma in multiple sclerosis. The Neurohospitalist 2011;1(3):133-6.
  10. Johnson BA, Fram EK, Johnson PC, et al. The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features. AJNR Am J Neuroradiol 1997;18(3):563-72.
  11. Boster A, Hreha S, Berger JR, et al. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol 2009;66(5):593-9.

Most read articles by the same author(s)